Injectable Drugs for Diabetes Part 4.docx

\#\#\# \*\*Slide 30: Insulin Therapy -- Bolus vs. Basal Insulin (Additional Questions)\*\* 1\. \*\*Which type of insulin is primarily used to control fasting blood glucose levels?\*\* \- A. Bolus insulin \- B. Basal insulin \- C. Rapid-acting insulin \- D. Intermediate-acting insulin \*\*Answe...

\#\#\# \*\*Slide 30: Insulin Therapy -- Bolus vs. Basal Insulin (Additional Questions)\*\* 1\. \*\*Which type of insulin is primarily used to control fasting blood glucose levels?\*\* \- A. Bolus insulin \- B. Basal insulin \- C. Rapid-acting insulin \- D. Intermediate-acting insulin \*\*Answer:\*\* B. Basal insulin 2\. \*\*Which insulin type is most commonly used to cover mealtime glucose spikes?\*\* \- A. Long-acting insulin \- B. NPH insulin \- C. Rapid-acting insulin \- D. Mixed insulin \*\*Answer:\*\* C. Rapid-acting insulin 3\. \*\*In a patient using both basal and bolus insulin, how does the basal insulin function throughout the day?\*\* \- A. It provides a continuous, steady release of insulin to maintain blood glucose between meals \- B. It peaks during meals to prevent postprandial hyperglycemia \- C. It acts as a backup for missed bolus doses \- D. It increases blood glucose levels to avoid hypoglycemia \*\*Answer:\*\* A. It provides a continuous, steady release of insulin to maintain blood glucose between meals \-\-- \#\#\# \*\*Slide 31: Blood Glucose Monitoring (Benefits)\*\* 1\. \*\*Which of the following is a key benefit of frequent blood glucose monitoring for patients with diabetes?\*\* \- A. It reduces the need for insulin therapy \- B. It helps patients track how diet and exercise impact blood sugar levels \- C. It prevents diabetic ketoacidosis (DKA) \- D. It eliminates the risk of hypoglycemia \*\*Answer:\*\* B. It helps patients track how diet and exercise impact blood sugar levels 2\. \*\*Frequent blood glucose monitoring may motivate patients by:\*\* \- A. Reducing the total daily insulin dose \- B. Showing immediate results of their lifestyle choices \- C. Lowering the cost of diabetes management \- D. Replacing the need for insulin therapy \*\*Answer:\*\* B. Showing immediate results of their lifestyle choices 3\. \*\*What is a potential psychological downside of frequent blood glucose monitoring?\*\* \- A. Depression due to constant focus on diabetes management \- B. Increased risk of hyperglycemia \- C. Development of insulin resistance \- D. Reduced accuracy of glucose readings \*\*Answer:\*\* A. Depression due to constant focus on diabetes management \-\-- \#\#\# \*\*Slide 32: When to Monitor Blood Glucose\*\* 1\. \*\*During which of the following situations is it most important to monitor blood glucose levels?\*\* \- A. While fasting or during an illness \- B. After every meal \- C. Only when switching from oral medication to insulin \- D. Only when hyperglycemia symptoms are present \*\*Answer:\*\* A. While fasting or during an illness 2\. \*\*Why should blood glucose be monitored more closely during pregnancy?\*\* \- A. To prevent hypoglycemia \- B. To detect gestational diabetes and prevent complications \- C. To lower the dose of insulin needed \- D. To stop all diabetes medications \*\*Answer:\*\* B. To detect gestational diabetes and prevent complications 3\. \*\*Which patient occupation may require more frequent blood glucose monitoring to reduce the risk of hypoglycemia while working?\*\* \- A. Office worker \- B. Truck driver \- C. Schoolteacher \- D. Software engineer \*\*Answer:\*\* B. Truck driver \-\-- \#\#\# \*\*Slide 33: Insulin Pump Therapy\*\* 1\. \*\*Which of the following is an advantage of using an insulin pump for diabetes management?\*\* \- A. Fewer daily blood glucose tests required \- B. More flexibility in daily activities like meals and exercise \- C. Reduced risk of diabetic ketoacidosis (DKA) \- D. Does not require insulin dosage adjustments \*\*Answer:\*\* B. More flexibility in daily activities like meals and exercise 2\. \*\*What type of insulin is used in insulin pumps for both basal and bolus delivery?\*\* \- A. Intermediate-acting insulin \- B. Long-acting insulin \- C. Rapid-acting insulin \- D. Inhaled insulin \*\*Answer:\*\* C. Rapid-acting insulin 3\. \*\*Which of the following is a potential downside of insulin pump therapy?\*\* \- A. Increased risk of diabetic retinopathy \- B. More frequent blood glucose testing \- C. Increased risk of catheter site infections \- D. Reduced control over glucose levels \*\*Answer:\*\* C. Increased risk of catheter site infections \-\-- \#\#\# \*\*Slide 34: Insulin Pump Mechanics\*\* 1\. \*\*What is the primary function of continuous subcutaneous insulin infusion (CSII) devices?\*\* \- A. To provide a basal dose of long-acting insulin \- B. To deliver individualized basal and bolus insulin doses based on self-monitored blood glucose levels \- C. To administer rapid-acting insulin in fixed doses \- D. To eliminate the need for carbohydrate counting \*\*Answer:\*\* B. To deliver individualized basal and bolus insulin doses based on self-monitored blood glucose levels 2\. \*\*Which type of insulin is specifically approved for use in insulin pumps due to favorable pharmacokinetics?\*\* \- A. Insulin glargine \- B. Insulin lispro \- C. Insulin detemir \- D. NPH insulin \*\*Answer:\*\* B. Insulin lispro 3\. \*\*How often should the catheter site be changed when using an insulin pump?\*\* \- A. Every 24 hours \- B. Every 7 days \- C. Every 3 days \- D. Every 12 hours \*\*Answer:\*\* C. Every 3 days \-\-- \#\#\# \*\*Slide 35: Continuous Glucose Monitoring (CGM)\*\* 1\. \*\*Which of the following is an advantage of continuous glucose monitoring (CGM) over traditional fingerstick blood glucose testing?\*\* \- A. Provides real-time glucose readings \- B. Requires less frequent calibration \- C. Eliminates the need for insulin adjustments \- D. Has fewer costs compared to traditional testing \*\*Answer:\*\* A. Provides real-time glucose readings 2\. \*\*Which of the following is a key parameter measured by continuous glucose monitoring (CGM)?\*\* \- A. Average daily insulin dose \- B. Time in range (TIR) \- C. Fasting glucose average \- D. Peak postprandial glucose \*\*Answer:\*\* B. Time in range (TIR) 3\. \*\*Which type of continuous glucose monitoring (CGM) device provides intermittent scanning of glucose levels?\*\* \- A. Intermittent scanned CGM (isCGM) \- B. Real-time CGM (rtCGM) \- C. Closed-loop system \- D. Self-monitoring blood glucose (SMBG) \*\*Answer:\*\* A. Intermittent scanned CGM (isCGM) \-\-- \#\#\# \*\*Slide 36: Glucose Monitoring Trends\*\* 1\. \*\*What is the benefit of tracking "time in range" (TIR) in diabetes management?\*\* \- A. It provides insight into the effectiveness of insulin therapy over time \- B. It predicts the long-term insulin needs of patients \- C. It measures how well the body is absorbing insulin \- D. It eliminates the need for HbA1c testing \*\*Answer:\*\* A. It provides insight into the effectiveness of insulin therapy over time 2\. \*\*What does the parameter "TAR" refer to in glucose monitoring?\*\* \- A. Time above range \- B. Total absorption rate \- C. Time for action of rapid insulin \- D. Titrated action of insulin \*\*Answer:\*\* A. Time above range 3\. \*\*Continuous glucose monitoring (CGM) has shown significant benefits in which of the following?\*\* \- A. Reducing the cost of diabetes management \- B. Improving glycemic control without increasing hypoglycemia risk \- C. Eliminating the need for bolus insulin \- D. Preventing weight gain in insulin-dependent patients \*\*Answer:\*\* B. Improving glycemic control without increasing hypoglycemia risk